-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QE7Sc/+j4o0XPWWvZkD7TetMGdjbeEPOgklmjFd2g0vQfkTDjjVxNq6k1f7e5Nfj GMpWh8hXSBFf1xfAefeRvQ== 0000943663-07-000115.txt : 20070403 0000943663-07-000115.hdr.sgml : 20070403 20070402204651 ACCESSION NUMBER: 0000943663-07-000115 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070403 DATE AS OF CHANGE: 20070402 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Chelsea Therapeutics International, Ltd. CENTRAL INDEX KEY: 0001333763 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203174202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81457 FILM NUMBER: 07741345 BUSINESS ADDRESS: STREET 1: 13950 BALLANTYNE CORPORATE PLACE STREET 2: UNIT 325 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 704-341-1516 MAIL ADDRESS: STREET 1: 13950 BALLANTYNE CORPORATE PLACE STREET 2: UNIT 325 CITY: CHARLOTTE STATE: NC ZIP: 28277 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AUSTIN JOSIAH T CENTRAL INDEX KEY: 0000932267 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: EL CORANADO RANCH STREET 2: STAR ROUTE BOX 395 CITY: PEARCE STATE: AZ ZIP: 85625 BUSINESS PHONE: 214-520-1684 MAIL ADDRESS: STREET 1: 4673 CHRISTOPHER PLACE CITY: DALLAS STATE: TX ZIP: 75204 SC 13D/A 1 sc13da2chtp.htm SC 13D 1ST AMENDMENT UNITED STATES

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

(Amendment No. 1)

 

 

Chelsea Therapeutics International, Ltd.

____________________________________________________________________________________

(Name of Issuer)

 

 

Common Stock, $.0001 par value

____________________________________________________________________________________

(Title of Class of Securities)

 

 

15100K201

_______________________________________________________

(CUSIP Number)

 

 

David J. Harris, Esq., 1775 Eye Street, N.W. Washington, D.C. 20006 (202) 261-3385

____________________________________________________________________________________

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

 

March 22, 2007

______________________________________________________

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [  ].

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 15100K201

1

NAME OF REPORTING PERSON

SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Josiah T. Austin

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [   ] (b) [x]

3

SEC USE ONLY

 

4

SOURCE OF FUNDS

OO

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [  ]

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

 

7

SOLE VOTING POWER

24,700 Shares

8

SHARED VOTING POWER

3,062,218 Shares

9

SOLE DISPOSITIVE POWER

24,700 Shares

10

SHARED DISPOSITIVE POWER

3,062,218 Shares

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,086,918 Shares

 

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES) [  ]

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

13.47%

14

TYPE OF REPORTING PERSON

IN


 

 

1

NAME OF REPORTING PERSON

SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

El Coronado Holdings, L.L.C.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [  ] (b) [x]

3

SEC USE ONLY

4

SOURCE OF FUNDS

WC

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [  ]

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Arizona

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

 

7

SOLE VOTING POWER

Not Applicable

8

SHARED VOTING POWER

3,062,218 Shares

9

SOLE DISPOSITIVE POWER

Not Applicable

10

SHARED DISPOSITIVE POWER

3,062,218 Shares

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,062,218 Shares

 

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [  ]

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

13.37%

14

TYPE OF REPORTING PERSON

HC


Item 1. Security and Issuer

    This Amendment No. 1 to the Statement on Schedule 13D heretofore filed on October 20, 2006 is filed with respect to the common stock, $0.0001 par value ("Common Stock"), of Chelsea Therapeutics International, Ltd. (the "Company"). The address of the Company is 13950 Ballantyne Corporate Place, Unit 325, Charlotte, North Carolina 28277. The Statement is being filed on behalf of Josiah T. Austin, a United States Citizen, and El Coronado Holdings, L.L.C. ("ECH"), an Arizona limited liability company whose principal place of business is 4673 Christopher Place, Dallas, Texas 75204 (collectively, the "Reporting Persons") to reflect the following amendments to Item 3 and Item 5.

Item 3. Source and Amount of Funds or Other Consideration

    Acting on behalf of ECH, Austin purchased from October 13, 2006 to March 22, 2007 a total of 41,485 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $204,702.95. The primary source of funds for these purchases was existing funds of ECH.

    Acting on behalf of ECH, on February 8, 2007, Austin purchased from several entities warrants immediately exercisable into 113,442 shares of Common Stock for an aggregate consideration (exclusive of brokers' commissions) of $218,375.85. The primary source of funds for these purchases was existing funds of ECH.

    Acting on behalf of ECH, on February 15, 2007, Austin purchased from an individual warrants immediately exercisable into 6,558 shares of Common Stock for an aggregate consideration (exclusive of brokers' commissions) of $12,624.12. The primary source of funds for these purchases was existing funds of ECH.

    Acting on behalf of ECH, on March 22, 2007, Austin acquired directly from the Company without charge warrants immediately exercisable into 430,614 shares of Common Stock.

    Acting on behalf of ECH, on March 22, 2007, Austin purchased a total of 1,435,381 shares of Common Stock directly from the Company for an aggregate consideration of $6,774,998.32. The primary source of funds for these purchases was existing funds of ECH.

    Acting on behalf of the A.L. Elias Trust, in his capacity as Trustee, Austin purchased on February 27, 2007 a total of 700 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $3,959.06. The primary source of funds for these purchases was existing funds of the Trust.

    Acting on behalf of the Anna L. Elias Trust, in his capacity as Trustee, Austin purchased on February 27, 2007 a total of 400 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $2,262.32. The primary source of funds for these purchases was existing funds of the Trust.

    Acting on behalf of the J.A. Lowery 2006 Grandchild Gift Trust, in his capacity as Trustee, Austin purchased on February 27, 2007 a total of 700 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $3,959.06. The primary source of funds for these purchases was existing funds of the Trust.

    Acting on behalf of the Josiah Zane Sylvester 2006 Grandchild Gift Trust, in his capacity as Trustee, Austin purchased on February 27, 2007 a total of 800 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $4,524.64. The primary source of funds for these purchases was existing funds of the Trust.

    Acting on behalf of the Josiah Zane Sylvester Trust, in his capacity as Trustee, Austin purchased on February 27, 2007 a total of 400 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $2,262.32. The primary source of funds for these purchases was existing funds of the Trust.

    Acting on behalf of the Austin-Clark Family Irrevocable Life Insurance Trust, in his capacity as Trustee, Austin purchased from February 28, 2007 to March 22, 2007 a total of 10,000 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $58,179.50. The primary source of funds for these purchases was existing funds of the Trust.

    Acting on behalf of the Josiah & Valer Austin Family Revocable Trust, in his capacity as Trustee, Austin purchased from February 28, 2007 to March 22, 2007 a total of 11,700 shares of Common Stock in open market transactions for an aggregate consideration (exclusive of brokers' commissions) of $67,019.50. The primary source of funds for these purchases was existing funds of the Trust.

All dollar amounts are in U.S. dollars.

Item 5. Interest in Securities of the Issuer

    (a)     Austin is the beneficial owner of 3,086,918 shares of Common Stock (which is 13.47% based on 22,910,977 shares outstanding as of March 23, 2007, as reported on the Company's 10-K filed on March 12, 2007 and the Company's 8-K filed on March 23, 2007), in his capacity as Trustee for certain family trusts and as sole Managing Member of ECH. ECH is the beneficial owner of 3,062,218 shares of Common Stock (which is 13.37% based on 22,910,977 shares outstanding as of March 23, 2007, as reported on the Company's 10-K filed on March 12, 2007 and the Company's 8-K filed on March 23, 2007). The total number of shares beneficially owned by Autin, as sole Managing Member of ECH, and by ECH directly include 550,614 shares of Common Stock that may be acquired through the exercise of various warrants, as described in Item 3 above.

    (b)     As Trustee of the Trusts, Austin has the sole power to vote or to dispose or direct the disposition of 24,700 shares of Common Stock. As sole Managing Member of ECH, Austin shares with ECH the power to vote or dispose or to direct the disposition of 3,062,218 shares of Common Stock.

    (c)     No transactions in the Company's Common Stock have been effected by the Reporting Persons during the last 60 days except the following transactions. Where applicable, prices do not include brokerage fees.

Security

Reporting Person

Sale/Purchase

Date

Quantity

Price Per Unit

Common Stock

Austin, on behalf of ECH

Purchase(1)

2/6/2007

12,057

5.625

Common Stock

Austin, on behalf of ECH

Purchase(1)

2/7/2007

1,668

5.650

Warrant

Austin, on behalf of ECH

Purchase(2)

2/8/2007

Exercisable into 113,442 shares of Common Stock

1.925

Warrant

Austin, on behalf of ECH

Purchase(2)

2/15/2007

Exercisable into 6,558 shares of Common Stock

1.925

Common Stock

Austin, on behalf of ECH

Purchase(1)

2/27/2007

1,719

5.656

Common Stock

Austin, on behalf of A.L.Elias Trust

Purchase(1)

2/27/2007

700

5.656

Common Stock

Austin, on behalf of Josiah Zane Sylvester 2006 Grandchild Gift Trust

Purchase(1)

2/27/2007

800

5.656

Common Stock

Austin, on behalf of Josiah Zane Sylvester Trust

Purchase(1)

2/27/2007

400

5.656

Common Stock

Austin, on behalf of of J.A. Lowery 2006 Grandchild Gift Trust

Purchase(1)

2/27/2007

700

5.656

Common Stock

Austin, on behalf of Anna L. Elias Trust

Purchase(1)

2/27/2007

400

5.656

Common Stock

Austin, on behalf of Josiah & Valer Austin Trust

Purchase(1)

2/28/2007

5,000

5.791

Common Stock

Austin, on behalf of Austin-Clark Family Irrevocable Life Insurance Trust

Purchase(1)

2/28/2007

5,000

5.791

Common Stock

Austin, on behalf of Josiah & Valer Austin Trust

Purchase(1)

3/1/2007

5,000

5.845

Common Stock

Austin, on behalf of Austin-Clark Family Irrevocable Life Insurance Trust

Purchase(1)

3/1/2007

5,000

5.845

Common Stock

Austin, on behalf of Josiah & Valer Austin Trust

Purchase(1)

3/20/2007

1,700

5.200

Common Stock

Austin, on behalf of ECH

Purchase(3)

3/22/2007

1,435,381

4.720

Warrant

Austin, on behalf of ECH

Purchase(4)

3/22/2007

Exercisable into 430,614 shares of Common Stock

0.0

Common Stock

Austin, on behalf of ECH

Purchase(1)

3/22/2007

12,000

5.497

 

_______________________________________

(1) Purchase was made in a broker's transaction in the open market.

(2) Warrants purchased directly from various entities.

(3) Purchased directly from the Company in a private placement transaction.

(4) Warrants received in connection with a private placement transaction without charge.

    (d)     No person other than the Reporting Persons has any right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, such securities.

    (e)     Not Applicable.


SIGNATURE

    After reasonable inquiry and to the best knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.

Date: April 2, 2007

 /s/ Josiah T. Austin

  

Josiah T. Austin,

  

Individually and as Sole Managing Member of ECH.

-----END PRIVACY-ENHANCED MESSAGE-----